> top > docs > PubMed:2077396 > annotations

PubMed:2077396 JSONTXT

Annnotations TAB JSON ListView MergeView

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 299-312 HP_0003002 denotes breast cancer
T2 299-312 HP_0100013 denotes breast cancer
T3 306-312 HP_0002664 denotes cancer
T4 394-399 HP_0002664 denotes tumor
T5 961-966 HP_0002664 denotes tumor
T6 1326-1339 HP_0003002 denotes breast cancer
T7 1326-1339 HP_0100013 denotes breast cancer
T8 1333-1339 HP_0002664 denotes cancer
T9 1363-1369 HP_0002664 denotes tumors
T10 1428-1434 HP_0002664 denotes tumors
T11 1554-1559 HP_0002664 denotes tumor
T12 1613-1618 HP_0002664 denotes tumor
T13 1633-1638 HP_0002664 denotes tumor
T14 1762-1775 HP_0003002 denotes breast cancer
T15 1762-1775 HP_0100013 denotes breast cancer
T16 1769-1775 HP_0002664 denotes cancer
T17 1899-1912 HP_0003002 denotes breast cancer
T18 1899-1912 HP_0100013 denotes breast cancer
T19 1906-1912 HP_0002664 denotes cancer

jnlpba-st-training

Id Subject Object Predicate Lexical cue
T1 0-17 protein denotes Estrogen receptor
T2 357-374 protein denotes estrogen receptor
T3 376-378 protein denotes ER
T4 967-969 protein denotes ER
T5 1025-1027 protein denotes ER
T6 1359-1361 protein denotes ER
T7 1463-1471 cell_type denotes NK cells
T8 1532-1546 cell_type denotes effector cells

pubmed-sentences-benchmark

Id Subject Object Predicate Lexical cue
S1 0-135 Sentence denotes Estrogen receptor concentration and social factors as predictors of natural killer cell activity in early-stage breast cancer patients.
S2 136-160 Sentence denotes Confirmation of a model.
S3 161-512 Sentence denotes Previous work of ours has demonstrated that a significant amount of natural killer (NK) activity variance after surgery in stage I and II breast cancer patients could be accounted for by both the estrogen receptor (ER) status of the tumor and by social factors, namely, perceived social support and seeking social support as a general coping strategy.
S4 513-872 Sentence denotes As considerable evidence has accumulated that social support in both animal and human populations may have survival value, we sought to test the reliability of this regression model, using coping and perceived support factor values obtained at 3 months after surgery to account for concurrent follow-up NK activity in this serially assessed group of patients.
S5 873-1036 Sentence denotes It was found that the most significant variable predicting NK activity at follow-up was tumor ER concentration, with higher NK activity associated with ER- status.
S6 1037-1266 Sentence denotes In addition, seeking social support as a coping strategy, as well as the perceived quality of support, also entered the model to account for a significant amount of NK activity variance (multivariate F = 5.25, p less than 0.001).
S7 1267-1669 Sentence denotes If, as the literature suggests, NK activity is relevant to breast cancer control, and since ER- tumors have a worse prognosis, we suggest here that perhaps such tumors are resistant to control by NK cells because they lack the ability to attract an accumulation of effector cells to the tumor site, or because blocking factors at the site of the tumor prevent local tumor control at the site of action.
S8 1670-1785 Sentence denotes The finding related to social support also replicates results from an independent sample of breast cancer patients.
S9 1786-1995 Sentence denotes This finding, taken together with other evidence that this social variable is associated with longer survival in breast cancer populations, underscores the potential importance of this social support variable.
S10 1996-2134 Sentence denotes Our findings also suggest one possible immunological variable involved, with potential clinical significance, for this patient population.

genia-medco-coref

Id Subject Object Predicate Lexical cue
C1 0-31 NP denotes Estrogen receptor concentration
C2 68-96 NP denotes natural killer cell activity
C3 152-159 NP denotes a model
C4 932-943 NP denotes NK activity
C5 961-983 NP denotes tumor ER concentration
C6 1153-1162 NP denotes the model
C7 1299-1310 NP denotes NK activity
C8 1359-1369 NP denotes ER- tumors
C9 1423-1434 NP denotes such tumors
C10 1480-1484 NP denotes they
C11 1550-1564 NP denotes the tumor site
C12 1597-1618 NP denotes the site of the tumor
C13 1650-1668 NP denotes the site of action
C14 1693-1707 NP denotes social support
C15 1820-1834 NP denotes other evidence
C16 1835-1839 NP denotes that
C17 1840-1860 NP denotes this social variable
C18 1899-1924 NP denotes breast cancer populations
C19 1966-1994 NP denotes this social support variable
C20 2110-2133 NP denotes this patient population
R1 C4 C2 coref-ident NK activity,natural killer cell activity
R2 C5 C1 coref-ident tumor ER concentration,Estrogen receptor concentration
R3 C6 C3 coref-ident the model,a model
R4 C7 C4 coref-ident NK activity,NK activity
R5 C9 C8 coref-ident such tumors,ER- tumors
R6 C10 C9 coref-pron they,such tumors
R7 C12 C11 coref-ident the site of the tumor,the tumor site
R8 C13 C12 coref-ident the site of action,the site of the tumor
R9 C16 C15 coref-relat that,other evidence
R10 C17 C14 coref-ident this social variable,social support
R11 C19 C17 coref-ident this social support variable,this social variable
R12 C20 C18 coref-ident this patient population,breast cancer populations

GENIAcorpus

Id Subject Object Predicate Lexical cue
T1 0-17 protein_family_or_group denotes Estrogen receptor
T2 36-50 other_name denotes social factors
T3 68-96 other_name denotes natural killer cell activity
T4 100-134 multi_cell denotes early-stage breast cancer patients
T5 229-266 other_name denotes natural killer (NK) activity variance
T6 357-374 protein_family_or_group denotes estrogen receptor
T7 376-378 protein_family_or_group denotes ER
T8 407-421 other_name denotes social factors
T9 441-455 other_name denotes social support
T10 468-482 other_name denotes social support
T11 496-511 other_name denotes coping strategy
T12 559-573 other_name denotes social support
T13 678-694 other_name denotes regression model
T14 816-827 other_name denotes NK activity
T15 863-871 multi_cell denotes patients
T16 932-943 other_name denotes NK activity
T17 961-966 other_name denotes tumor
T18 967-969 protein_family_or_group denotes ER
T19 997-1008 other_name denotes NK activity
T20 1025-1027 protein_family_or_group denotes ER
T21 1058-1072 other_name denotes social support
T22 1202-1213 other_name denotes NK activity
T23 1299-1310 other_name denotes NK activity
T24 1326-1347 other_name denotes breast cancer control
T25 1359-1361 protein_family_or_group denotes ER
T26 1428-1434 tissue denotes tumors
T27 1463-1471 cell_type denotes NK cells
T28 1532-1546 cell_type denotes effector cells
T29 1554-1564 other_name denotes tumor site
T30 1577-1593 other_name denotes blocking factors
T31 1633-1646 other_name denotes tumor control
T32 1693-1707 other_name denotes social support
T33 1762-1775 multi_cell denotes breast cancer
T34 1776-1784 multi_cell denotes patients
T35 1899-1924 other_name denotes breast cancer populations
T36 1971-1985 other_name denotes social support
T37 2035-2066 other_name denotes immunological variable involved
T38 2083-2104 other_name denotes clinical significance
T39 2115-2133 multi_cell denotes patient population